MXPA04005038A - Solvatos de paclitaxel. - Google Patents

Solvatos de paclitaxel.

Info

Publication number
MXPA04005038A
MXPA04005038A MXPA04005038A MXPA04005038A MXPA04005038A MX PA04005038 A MXPA04005038 A MX PA04005038A MX PA04005038 A MXPA04005038 A MX PA04005038A MX PA04005038 A MXPA04005038 A MX PA04005038A MX PA04005038 A MXPA04005038 A MX PA04005038A
Authority
MX
Mexico
Prior art keywords
solvates
paclitaxel
paclitaxel solvates
aprotic
precipitated
Prior art date
Application number
MXPA04005038A
Other languages
English (en)
Inventor
D Dimarco John
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MXPA04005038A publication Critical patent/MXPA04005038A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a solvatos cristalinos de pacliaxel biologicamente activos, los cuale on precipitado usando solventes organicos, aproticos, polares. Tambien se describe una composicion farmaceutica, asi como tambien la preparacion de los nuevo solvatos y sus usos como agentes anti-tumores.
MXPA04005038A 2001-11-30 2002-11-25 Solvatos de paclitaxel. MXPA04005038A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33489601P 2001-11-30 2001-11-30
PCT/US2002/037901 WO2003047508A2 (en) 2001-11-30 2002-11-25 Paclitaxel solvates

Publications (1)

Publication Number Publication Date
MXPA04005038A true MXPA04005038A (es) 2004-08-11

Family

ID=23309330

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005038A MXPA04005038A (es) 2001-11-30 2002-11-25 Solvatos de paclitaxel.

Country Status (13)

Country Link
US (1) US6858644B2 (es)
EP (1) EP1451168A4 (es)
JP (1) JP4451660B2 (es)
KR (1) KR20050044621A (es)
CN (1) CN1596250A (es)
AU (1) AU2002365883A1 (es)
BR (1) BR0214277A (es)
HU (1) HUP0600533A2 (es)
IL (1) IL161372A0 (es)
MX (1) MXPA04005038A (es)
PL (1) PL368945A1 (es)
TW (1) TW200300671A (es)
WO (1) WO2003047508A2 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
CA2492015A1 (en) * 2002-07-17 2004-01-29 Cph Innovations Corporation Low polarity dimerate and trimerate esters as plasticizers for elastomers
US8703982B2 (en) 2003-03-17 2014-04-22 Phyton Holdings Llc Purification of taxanes
US20070142457A1 (en) * 2005-10-12 2007-06-21 Alessandro Pontiroli Crystalline forms of docetaxel and processes for their preparation
US7919108B2 (en) * 2006-03-10 2011-04-05 Cook Incorporated Taxane coatings for implantable medical devices
US20080286325A1 (en) * 2006-01-05 2008-11-20 Med Institute, Inc. Cyclodextrin elution media for medical device coatings comprising a taxane therapeutic agent
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
MX2008014953A (es) * 2006-05-26 2009-03-05 Bayer Healthcare Llc Combinaciones de medicamentos con diarilureas sustituidas para el tratamiento de cancer.
WO2008005284A2 (en) 2006-06-30 2008-01-10 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
EP2491962A1 (de) 2007-01-21 2012-08-29 Hemoteq AG Medizinprodukt zur Behandlung von Verschlüssen von Körperdurchgängen und zur Prävention drohender Wiederverschlüsse
US9192697B2 (en) * 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
DE102007036685A1 (de) 2007-08-03 2009-02-05 Innora Gmbh Verbesserte arzneimittelbeschichtete Medizinprodukte deren Herstellung und Verwendung
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
IT1394522B1 (it) 2009-01-09 2012-07-05 Invatec Technology Ct Gmbh Dispositivo medicale con rilascio di farmaco
ES2550634T3 (es) 2009-07-10 2015-11-11 Boston Scientific Scimed, Inc. Uso de nanocristales para un balón de suministro de fármaco
US10080821B2 (en) 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US20120078227A1 (en) 2010-09-23 2012-03-29 Boston Scientific Scimed, Inc. Drug Coated Balloon Composition with High Drug Transfer to Vessel
KR20140018917A (ko) * 2011-04-12 2014-02-13 플러스 케미칼스, 에스.에이. 카바지탁셀의 고상 형태 및 이의 제조 방법
WO2013022458A1 (en) 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
WO2013162922A1 (en) * 2012-04-25 2013-10-31 Genta Incorporated Taxane compounds, compositions and methods
US11167063B2 (en) 2013-03-14 2021-11-09 W. L. Gore & Associates, Inc. Porous composites with high-aspect ratio crystals
US9872940B2 (en) 2013-04-01 2018-01-23 Terumo Kabushiki Kaisha Drug coating layer
CN103833693B (zh) * 2014-03-04 2016-02-24 悦康药业集团有限公司 一种紫杉醇化合物及含该紫杉醇化合物的药物组合物
WO2015151877A1 (ja) 2014-04-01 2015-10-08 テルモ株式会社 バルーンコーティング方法、コート層制御方法およびバルーンコーティング装置
CN106132469B (zh) 2014-04-01 2019-11-15 泰尔茂株式会社 球囊涂敷方法
JP6498664B2 (ja) 2014-04-01 2019-04-10 テルモ株式会社 バルーンコーティングのための位置決め方法およびバルーンコーティング方法
WO2015151878A1 (ja) 2014-04-01 2015-10-08 テルモ株式会社 バルーンコーティングのための位置決め方法
US10149925B2 (en) 2014-05-16 2018-12-11 Terumo Kabushiki Kaisha Method of reducing the risk of embolization of peripheral blood vessels
US10143779B2 (en) 2014-05-16 2018-12-04 Terumo Kabushiki Kaisha Method of inhibiting thickening of vascular intima
US10188771B2 (en) 2014-05-16 2019-01-29 Terumo Kabushiki Kaisha Method of treating peripheral artery diseases in lower limbs
US9901719B2 (en) 2015-04-23 2018-02-27 Terumo Kabushiki Kaisha Balloon coating method, balloon rotating method and balloon coating apparatus
US10561766B2 (en) 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating
JP6472572B2 (ja) 2016-03-23 2019-02-20 テルモ株式会社 バルーンカテーテルおよびその製造方法並びに処置方法

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536334A (en) 1979-06-28 1985-08-20 Sumitomo Chemical Company, Limited Preparation of β-lactam derivatives
US4294012A (en) * 1980-03-25 1981-10-13 Lanz Donald D Chain saw anti-pinch guard arm
EP0176064A1 (en) 1980-11-06 1986-04-02 Hoechst Uk Limited Intermediates for the production of 7-oxo-4-thia-1-aza[3,2,0]heptane and 7-oxo-4-thia-1-aza[3,2,0]hept-2-ene derivatives
HU187685B (en) 1981-03-30 1986-02-28 Squibb & Sons Inc Process for preparing 2-oxo-1-/substituted phosphinyl/-azetidines
US4492757A (en) 1981-12-28 1985-01-08 Denki Kagaku Kogyo Kabushiki Kaisha Process for preparing L-threonine
US4680391A (en) 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
JPS60139667A (ja) 1983-12-27 1985-07-24 Takeda Chem Ind Ltd アゼチジノンの製造法
CA1256444A (en) 1986-04-30 1989-06-27 Kazunori Kan Process for preparing 4-acetoxy-3- hydroxyethylazetidin-2-one derivatives
FR2601675B1 (fr) 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601676B1 (fr) 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
US4876399A (en) 1987-11-02 1989-10-24 Research Corporation Technologies, Inc. Taxols, their preparation and intermediates thereof
US4942184A (en) 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
FR2629818B1 (fr) 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
FR2629819B1 (fr) 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US4943528A (en) 1988-11-22 1990-07-24 Nitto Chemical Industry Co., Ltd. Process for the production of optically active (R)-(-)-3-halo-1,2-propanediol
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
CA2012364A1 (en) 1989-04-01 1990-10-01 Fumio Moriuchi Optically active compound and process for preparing the same
WO1990014434A1 (en) 1989-05-15 1990-11-29 Schering Corporation Process for preparing antibacterial compounds and intermediates thereto
MY110249A (en) 1989-05-31 1998-03-31 Univ Florida State Method for preparation of taxol using beta lactam
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
EP0404586A3 (en) 1989-06-21 1991-12-11 Merck & Co. Inc. Nitrogen deprotected 4-acyloxyazetidin-2-ones
IL95436A (en) 1989-08-23 1996-07-23 Centre Nat Rech Scient Process for preparing the history of phenylisosarine
US5241064A (en) 1989-10-02 1993-08-31 Fujisawa Pharmaceutical Co., Ltd. Enzymatic process for preparing optically active 3-substituted azetidinones
US5015744A (en) 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone
US5136060A (en) 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
US5059699A (en) 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5278324A (en) 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5380916A (en) * 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
US5475120A (en) 1990-11-02 1995-12-12 University Of Florida Method for the isolation and purification of taxol and its natural analogues
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2671799B1 (fr) 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa La b-phenylisoserine-(2r, 3s), ses sels, sa preparation et son emploi.
FR2679230B1 (fr) 1991-07-16 1993-11-19 Rhone Poulenc Rorer Sa Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
CA2071160A1 (en) 1991-07-31 1993-02-01 Vittorio Farina Asymmetric synthesis of taxol side chain
EP0529483B1 (de) 1991-08-22 1996-02-28 Lonza Ag Verfahren zur Herstellung von optisch aktiven 4-Amino-3-hydroxycarbonsäuren
US5250683A (en) 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5489601A (en) 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
US5229526A (en) 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5284865A (en) 1991-09-23 1994-02-08 Holton Robert A Cyclohexyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5274124A (en) 1991-09-23 1993-12-28 Florida State University Metal alkoxides
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
HU226369B1 (en) 1991-09-23 2008-09-29 Univ Florida State Process for preparing substituted isoserine-esters using metal alkoxides and beta-lactams
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
CA2434312A1 (en) 1992-01-15 1993-07-16 Ramesh N. Patel Enzymatic processes for resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
IT1258838B (it) 1992-01-31 1996-02-29 Indena Spa Processo per l'estrazione di tassolo e derivati da cultivar del genere taxus
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5451392A (en) 1992-03-03 1995-09-19 The Research And Development Institute At Montana State University Production of taxol
JPH069600A (ja) 1992-05-06 1994-01-18 Bristol Myers Squibb Co タクソールのベンゾエート誘導体
US5248796A (en) 1992-06-18 1993-09-28 Bristol-Myers Squibb Company Taxol derivatives
US5254580A (en) 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
US5294637A (en) 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
EP0582469A2 (en) 1992-08-06 1994-02-09 Wisconsin Alumni Research Foundation Process for preparing taxol-type compound from beta-lactam precursors
EP0627010A4 (en) 1992-12-07 1995-05-03 Univ Michigan PROCESS FOR ISOLATION AND PURIFICATION OF TAXOL AND TAXANES FROM -i (TAXUS) spp.
US5279949A (en) 1992-12-07 1994-01-18 Board Of Trustees Operating Michigan State University Process for the isolation and purification of taxol and taxanes from Taxus spp
CA2111527C (en) 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethyl ethers of taxane derivatives
US5646176A (en) 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
US5523219A (en) 1993-06-15 1996-06-04 Bristol-Myers Squibb Company Enzymatic hydrolysis method for the preparation of C-10 hydroxyl-bearing taxanes and enzymatic esterification method for the preparation of C-10 acyloxy-bearing
US5516676A (en) 1993-06-15 1996-05-14 Bristol-Myers Squibb Company Preparation of C-13 hydroxyl-bearing taxanes using nocardioides or a hydrolase isolated therefrom
CA2163837C (en) 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates
WO1997009443A1 (en) 1995-09-05 1997-03-13 Michigan State University PROCESS FOR THE ISOLATION AND PURIFICATION OF TAXOL AND TAXANES FROM TAXUS spp
US5877205A (en) * 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
US6221153B1 (en) * 1998-06-09 2001-04-24 Trevor Percival Castor Method for producing large crystals of complex molecules
US6017948A (en) * 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
US6136989A (en) 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
PL203300B1 (pl) * 2000-10-31 2009-09-30 Akad Medyczna Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego
EP1349357B1 (en) 2000-12-26 2008-09-24 ARKRAY, Inc. Call center system

Also Published As

Publication number Publication date
PL368945A1 (en) 2005-04-04
WO2003047508A3 (en) 2003-10-30
JP4451660B2 (ja) 2010-04-14
KR20050044621A (ko) 2005-05-12
AU2002365883A1 (en) 2003-06-17
IL161372A0 (en) 2004-09-27
WO2003047508A2 (en) 2003-06-12
EP1451168A2 (en) 2004-09-01
JP2005511646A (ja) 2005-04-28
US20030144344A1 (en) 2003-07-31
BR0214277A (pt) 2004-09-21
US6858644B2 (en) 2005-02-22
TW200300671A (en) 2003-06-16
HUP0600533A2 (en) 2006-11-28
CN1596250A (zh) 2005-03-16
EP1451168A4 (en) 2005-08-24

Similar Documents

Publication Publication Date Title
MXPA04005038A (es) Solvatos de paclitaxel.
PL367682A1 (en) Dolastatin 10 derivatives
GEP20074099B (en) 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
PL366198A1 (en) Novel compounds
AU2002316459A1 (en) Methods of treating cytokine mediated diseases
EP1852437A3 (en) 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
HK1048990A1 (en) Novel compounds.
MY137774A (en) Acetylene derivatives having mglur5 antagonistic activity
IL160051A0 (en) Ecteinascidin derivatives and pharmaceutical compositions containing the same
HRP20020330B1 (es)
GEP20084284B (en) Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
WO2004000859A3 (en) Etoposide analogs and methods of use thereof
EP1548025A3 (en) Sapogenin derivatives and their use in the treatment of cognitive dysfunction
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
MXPA03010761A (es) Combinaciones farmaceuticas.
AU2003288869A1 (en) PYRAZOLO (3,4-d) PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION
AU2001286768A1 (en) Novel macrocycles and uses thereof
SE0101038D0 (sv) Novel compounds
IL172538A0 (en) Depsipeptide compounds, pharmaceutical compositions containing the same and processes for the preparation thereof
ATE497967T1 (de) Interzelluläre kommunikation erleichternden verbindungen und deren medizinischen verwendungen
SI1532131T1 (sl) Motilidne spojine
NZ530587A (en) Diazacycloalkanes as oxytocin agonists
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
WO2001005386A3 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
TW200509794A (en) Novel anthelmintic and insecticidal compositions

Legal Events

Date Code Title Description
FG Grant or registration